Re:WHO asks South African startup to replicate Moderna's mRN...
by JumpCrisscross on Wednesday October 20, 2021 @03:43PM
(#28935250)
> in this global emergency, the benefits massively outweigh the risks
There is more than enough money to buy doses for everyone in the world at sticker price. This isn’t a debate about whether lives get saved, but about who pays for it.
There is more than enough money to buy doses for everyone in the world at sticker price. This isn’t a debate about whether lives get saved, but about who pays for it.